The Research Governance Unit will be closing for the Christmas period on the 18 December 2020 and reopening on the 04 January 2021.
St Vincent's is a major teaching, research and tertiary referral centre providing acute or chronic medical and surgical services, as well as clinical training.
Our commitment to innovative care is reflected by the passion for health and medical research evident across St Vincent’s campus and our partners, translating the findings of our scientists into meaningful improvements in clinical care.By participating in world-class research, we deliver hope to our patients and community and help determine the future of health care locally and globally.
We have established our innovative RESEARCH VALET® to assist with project submission for HREC review and also to speed the approval process. And we have sought to build productive relationships with industry to benefit both patients and clinicians with access to a wider range of clinical trials. Please click here for information regarding the RESEARCH VALET®.
Covid-19 Related Information
St Vincent's is working closely with the State Government’s Department of Health to help protect and keep safe our patients, visitors, staff and doctors from COVID-19. Our hospital remains open and fully functional, with the appropriate safeguards and containment precautions now in place.
The Research Directorate and RGU are now activating our “Work from Home” policy as of 23rd March 2020. No RGU staff will be onsite, but all our individual landlines have been diverted and will be answered by the respective staff. All ethics and governance submissions can only be accepted and processed via electronic formats as per our guideline.
Our ethics committee meetings will continue to operate as per schedule via online video and phone access.
The Research Directorate has developed the "Plan for managing Clinical Trials in the setting of COVID19 disruption (18th March 2020, re-issued 10th July 2020)", for our staff, trial participants, research collaborators and clinical trials sponsors, see link for more details.
SVHM is pleased to announce they have remote monitoring capability.
Please see the below guidelines on how to establish a Monitor to undertake remote monitoring:
For Ethics & Governance related matter please call 03 9231 2394 or email: email@example.com
For Research Valet related matter please call 03 9231 3915 or email: firstname.lastname@example.org
Dr Megan Robertson, Director of Research t: 03 9231 3895 email: email@example.com
Dr Tam Nguyen, Deputy Director of Research t: 03 9231 3930 email: firstname.lastname@example.org
SVHM Researchers Awarded Prestigious Grants
We are delighted to announce SVHM clinician researchers Dr Emily Wright and Dr Kathleen Morrisroe were awarded the NHMRC Grant 2020 for their work in Microbial Restoration in Crohn's Disease and Systematic Sclerosis related PAH respectively.
Another fantastic achievement was that of A/Prof Claudia Di Bella, SVHM Orthopaedic Surgeon researcher, for receiving the hihgly-competitive Medical Research Future Fund for her work in 3D printing for regenerative joint cartilage.
Dr Emily Wright - Microbial Restoration in Crohn's Disease: A Randomised Trial of Faecal Microbial Transplantation in Crohn's Disease
Dr Kathleen Morrisroe - Improving outcomes and cost of systemic sclerosis related pulmonary arterial hypertension
Dr Claudia Di Bella - Putting 3D printing into the reality of surgery: an approach for regenerating joint cartilage within the body using one-step surgery.